Advertisement
Screener

Abivax S.A. (ABVX) Interest Received Classified As Investing Activities

2.5 / 5 stars · 5/10 Roast Me

Abivax S.A. Interest Received Classified As Investing Activities

Abivax S.A. (ABVX) reported Interest Received Classified As Investing Activities of EUR 5.53 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.

Financial Statements › Cash Flow › Investing Activities

ifrs-full:InterestReceivedClassifiedAsInvestingActivities · last filed 2026-03-23

  • Abivax S.A. interest received classified as investing activities for the quarter ending 2025-12-31 was 896.00K EUR, a 28.83% decline year-over-year.
  • Abivax S.A. interest received classified as investing activities for the quarter ending 2025-09-30 was 3.46M EUR, a 69.41% increase year-over-year.
  • Abivax S.A. interest received classified as investing activities for the quarter ending 2025-06-30 was 194.00K EUR, a 92.00% decline year-over-year.
  • Abivax S.A. interest received classified as investing activities for the quarter ending 2025-03-31 was 984.00K EUR, a 59.90% decline year-over-year.
Period endInterest Received Classified As Investing Activities 3 monthInterest Received Classified As Investing Activities 6 monthInterest Received Classified As Investing Activities 9 monthInterest Received Classified As Investing Activities 12 month
2025-12-31896.00K EUR
derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23
4.35M EUR
derived: sum of 2 quarters · filed 2026-03-23
4.55M EUR
derived: sum of 3 quarters · filed 2026-03-23
5.53M EUR
20-F · filed 2026-03-23
2025-09-303.46M EUR
derived: 6-K 9 month − 6-K 6 month · filed 2025-12-15
3.65M EUR
derived: sum of 2 quarters · filed 2025-12-15
4.63M EUR
6-K · filed 2025-12-15
5.89M EUR
derived: sum of 4 quarters · filed 2026-03-23
2025-06-30194.00K EUR
derived: 6-K 6 month − 6-K 3 month · filed 2025-09-08
1.18M EUR
6-K · filed 2025-09-08
2.44M EUR
derived: sum of 3 quarters · filed 2026-03-23
4.48M EUR
derived: sum of 4 quarters · filed 2026-03-23
2025-03-31984.00K EUR
6-K · filed 2025-06-02
2.24M EUR
derived: sum of 2 quarters · filed 2026-03-23
4.28M EUR
derived: sum of 3 quarters · filed 2026-03-23
6.71M EUR
derived: sum of 4 quarters · filed 2026-03-23
2024-12-311.26M EUR
derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23
3.30M EUR
derived: sum of 2 quarters · filed 2026-03-23
5.72M EUR
derived: sum of 3 quarters · filed 2026-03-23
8.18M EUR
20-F · filed 2026-03-23
2024-09-302.04M EUR
derived: 6-K 9 month − 6-K 6 month · filed 2025-12-15
4.46M EUR
derived: sum of 2 quarters · filed 2025-12-15
6.92M EUR
6-K · filed 2025-12-15
2024-06-302.42M EUR
derived: 6-K 6 month − 6-K 3 month · filed 2025-09-08
4.88M EUR
6-K · filed 2025-09-08
2024-03-312.45M EUR
6-K · filed 2025-06-02
2023-12-312.40M EUR
20-F · filed 2026-03-23
2022-12-3119.00K EUR
20-F · filed 2025-03-24
2021-12-310.00 EUR
20-F · filed 2024-04-05